Pylera Axcan Pharma Inc. - Treatment for Eradication of Helicobacter pylori
Pylera is a 3-in-1 capsule triple therapy indicated for the eradication of Helicobacter pylori, a bacterium now recognized as being the main cause of gastric and duodenal ulcers.Posted: September 2006
Related articles
- Axcan submits FDA amendment to its new drug application for Helizide - March 29, 2006
Pylera (bismuth subcitrate potassium, metronidazole and tetracycline) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
